Devyser Diagnostics AB announced it has entered into a co-marketing agreement with Hamilton Bonaduz AG, a leading global manufacturer of laboratory automation technology. The partnership enables Devyser to collaboratively market Hamilton liquid handling technologies, and to facilitate the automation of library preparation of Devyser NGS kits. This enables labs to benefit from a combined solution of simple, fast, and accurate genetic testing solutions from Devyser alongside precise and reliable automation technologies from Hamilton, thereby enhancing the product value for both companies.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
112 SEK | +2.75% | +0.90% | +42.49% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.49% | 175M | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- DVYSR Stock
- News Devyser Diagnostics AB
- Devyser Diagnostics AB Enters into Co-Marketing Agreement with Hamilton Bonaduz AG